Introduction Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver
disease, with type 2 diabetes mellitus (T2DM) as a major predictor. Insulin resistance and …

Introduction There exists clinical interest in the following question: Is there an association
between HOMA-IR and the risk of developing metabolic diseases? Aims Assessing the …

Abstract Aims/hypothesis Recent European guidelines for non-alcoholic fatty liver disease
(NAFLD) call for reference values for HOMA-IR. In this study, we aimed to determine:(1) the …

NAFLD is the most common chronic liver disease worldwide, occurring in both obese and
lean patients. It can lead to life-threatening liver diseases and nonhepatic complications …

The prevalence of non-alcoholic fatty liver disease (NAFLD), one of the most common liver
diseases, is rising. About 25% of adults worldwide are probably affected by NAFLD. Insulin …

We determined the relationships between metabolic score for IR (METS-IR), triglyceride-
glucose (TyG) index, and homeostatic model assessment for IR (HOMA-IR) and incident …

Objective To assess the associations between the triglyceride glucose (TyG) index and
modified TyG indices with nonalcoholic fatty liver disease (NAFLD) and evaluate their ability …

Intragastric balloon (IGB) therapy has shown efficacy in weight loss but its role in NAFLD
remains unknown. We conducted a systematic review and meta-analysis to evaluate the …

Lycium barbarum polysaccharide (LBP), as one bioactive macromolecular abstracted from
goji berry, has shown an abundance of potential function. The present study aimed to …

Background and objective Patients with non-alcoholic fatty liver disease (NAFLD) have
insulin resistance and are at an increased risk of diabetes. Recent evidence suggests that …